“…Interestingly, the problems with serotype distribution based on geographical location can impact a protein-based vaccine too. A study using PCR detection of many of the discussed pneumococcal surface proteins observed non-uniform presence of multiple proteins originally expected to be conserved ( Blumental et al., 2015 ), while another study showed downregulation of PcpA and PhtE and no changes in PLY, PspA, or PhtD when comparing serotypes 15A and 35B, two serotypes with increasing incidence rates and outside of PCV coverage ( Fuji et al., 2021 ). Partly due to these reasons, a growing effort has developed for a multi-component approach as opposed to individual proteins in vaccine design ( Table 2 ).…”